[PLX] QoQ Quarter Result on 31-Mar-2016 [#Q1]

Stock
[PLX] Protalix BioTherapeutics, Inc.
Announcement Date
09-May-2016
Financial Year
2016
Quarter
31-Mar-2016 [#Q1]
Profit Trend
QoQ- -111.79%
YoY- -43.97%
Quarter Report
PLX's Result
PLX's Financial Summary
View:
Show?
Quarter Result
31/12/16 30/09/16 30/06/16 31/03/16 31/12/15 30/09/15 30/06/15 CAGR
Revenue 2,081 4,670 1,769 679 -11,195 5,846 4,616 -41.06%
PBT -2,624 -7,290 -10,736 -8,526 -12,419 -3,820 -5,071 -35.41%
Tax -189 268 213 314 -85,260 17 43 -
NP -2,624 -7,290 -10,853 -8,598 72,900 -3,820 -5,071 -35.41%
Tax Rate - - - - - - - -
Total Cost 4,705 11,960 12,622 9,277 -84,095 9,666 9,687 -38.07%
Ratio Analysis
31/12/16 30/09/16 30/06/16 31/03/16 31/12/15 30/09/15 30/06/15 CAGR
NP Margin -126.09 -156.10 -613.51 -1,266.27 -651.18 -65.34 -109.86 9.57%
Per Share
31/12/16 30/09/16 30/06/16 31/03/16 31/12/15 30/09/15 30/06/15 CAGR
EPS -0.21 -0.07 -0.11 -0.09 7.31 -0.04 -0.05 159.18%
EPS Diluted -0.21 -0.07 -0.11 -0.09 7.31 -0.04 -0.05 159.18%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.